Low-Abundance Serum Proteins as Biomarkers for Cardiovascular Disease
Many individuals with cardiovascular disease (CVD) do not present with any of the disorder’s classic risk factors. Circulating proteins are a promising source for CVD biomarkers to complement existing clinically-relevant indicators. These proteins are often released at the very onset of CVD, well before visible manifestations or symptoms. However, detecting them at these low concentrations is a challenge.
Download this white paper from SomaLogic to learn how the SomaScan® assay overcomes obstacles linked with other assays, including insufficient detection sensitivity, non-specificity, and cross-reactivity.
Never miss an email from The Scientist. Click hereto add The Scientist to your safe-sender list.
The Scientist,1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll-Free: (888) 781-0328 | Phone: (705) 528-6888 Email: privacy@the-scientist.com